Patents by Inventor Rolf Lood

Rolf Lood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230212543
    Abstract: The present invention relates to a novel endoprotease, mutants thereof having binding but lacking or having reduced hydrolyzing activity, and use in methods of studying and isolating O-linked glycoproteins.
    Type: Application
    Filed: December 22, 2022
    Publication date: July 6, 2023
    Inventors: Fredrik Leo, Rolf Lood, Stephan Bjork, Malin Mejare, Fredrik Olsson
  • Patent number: 11584922
    Abstract: The present invention relates to a novel endoprotease, mutants thereof having binding but lacking or having reduced hydrolyzing activity, and use in methods of studying and isolating O-linked glycoproteins.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: February 21, 2023
    Assignee: Genovis AB
    Inventors: Fredrik Leo, Rolf Lood, Stephan Bjork, Malin Mejare, Fredrik Olsson
  • Publication number: 20220000762
    Abstract: The present application relates to the use of compositions comprising a live C. acnes strain secreting RoxP (radical oxygenase of Propionibacterium acnes) and compositions comprising RoxP or a biologically active variant or fragment thereof for treating or preventing oxidative stress-associated skin diseases or for preventing or reducing skin ageing. The application further relates to method for diagnosing oxidative stress-associated skin disease in a subject or for determining the benefit a subject would receive from administration of RoxP or a live C. acnes strain secreting RoxP, the methods comprising determining the quantity of RoxP or the quantity of C. acnes in a skin sample from the subject.
    Type: Application
    Filed: November 15, 2019
    Publication date: January 6, 2022
    Applicant: S-Biomedic N.V.
    Inventor: Rolf Lood
  • Patent number: 11180744
    Abstract: Acinetobacter lysin polypeptides and variants peptides with killing activity against gram negative bacteria. Methods for treating bacterial infections or bacterial colonization using Acintobacter lysin polypeptides.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: November 23, 2021
    Assignee: The Rockefeller University
    Inventors: Vincent Fischetti, Raymond Schuch, Rolf Lood, Benjamin Winer
  • Publication number: 20200172889
    Abstract: The present invention relates to a novel endoprotease, mutants thereof having binding but lacking or having reduced hydrolyzing activity, and use in methods of studying and isolating O-linked glycoproteins.
    Type: Application
    Filed: May 25, 2018
    Publication date: June 4, 2020
    Inventors: Fredrik Leo, Rolf Lood, Stephan Bjork, Malin Mejare, Fredrik Olsson
  • Publication number: 20200087643
    Abstract: The present invention relates to enzymes and combinations thereof useful for studying glycoproteins, and corresponding methods of use. In particular, the invention relates to a sialidase composition comprising an additional protease and/or glycosidase, preferably an O-glycoprotein-specific endoprotease and/or an O-glycosidase.
    Type: Application
    Filed: May 25, 2018
    Publication date: March 19, 2020
    Inventors: Fredrik Leo, Rolf Lood, Stephan Bjork, Malin Mejare, Fredrik Olsson
  • Patent number: 10590403
    Abstract: Acinetobacter lysin polypeptides and variants peptides with killing activity against gram negative bacteria. Methods for treating bacterial infections or bacterial colonization using Acinetobacter lysin polypeptides.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: March 17, 2020
    Assignee: The Rockefeller University
    Inventors: Vincent Fischetti, Raymond Schuch, Rolf Lood, Benjamin Winer
  • Publication number: 20190345467
    Abstract: Acinetobacter lysin polypeptides and variants peptides with killing activity against gram negative bacteria. Methods for treating bacterial infections or bacterial colonization using Acintobacter lysin polypeptides.
    Type: Application
    Filed: June 26, 2019
    Publication date: November 14, 2019
    Inventors: Vincent Fischetti, Raymond Schuch, Rolf Lood, Benjamin Winer
  • Patent number: 9707279
    Abstract: The invention provides an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, for use in a method for treating or preventing a disease or condition mediated by IgE antibodies.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: July 18, 2017
    Assignee: Hansa Medical AB
    Inventors: Mattias Collin, Rolf Lood, Karl Carlstrom, Maria Allhorn, Jonathan Sjogren, Falk Nimmerjahn
  • Publication number: 20170130214
    Abstract: Acinetobacter lysin polypeptides and variants peptides with killing activity against gram negative bacteria. Methods for treating bacterial infections or bacterial colonization using Acinetobacter lysin polypeptides.
    Type: Application
    Filed: June 26, 2015
    Publication date: May 11, 2017
    Applicant: The Rockefeller University
    Inventors: Vincent Fischetti, Raymond Schuch, Rolf Lood, Benjamin Winer
  • Publication number: 20140065128
    Abstract: The invention provides an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, for use in a method for treating or preventing a disease or condition mediated by IgE antibodies.
    Type: Application
    Filed: March 5, 2012
    Publication date: March 6, 2014
    Applicant: HANSA MEDICAL AB
    Inventors: Mattias Collin, Rolf Lood, Karl Carlstrom, Maria Allhorn, Jonathan Sjogren, Falk Nimmerjahn